Mini Review
Volume 7 Issue 3 - 2020
Gut Dysbiosis
Carlos Castañeda Guillot1,2*
1Emeritus Professor, Faculty of Medicine, Autonomous Regional University of Los Andes, Ecuador
2Consulting Professor, Senior Research, Calixto Garcia Medical Faculty, Medical University of Havana, Cuba
*Corresponding Author: Carlos Castañeda Guillot, Emeritus Professor Faculty of Medicine, Autonomous Regional University of Los Andes, Ambato, Ecuador.
Received: January 14, 2020; Published: February 07, 2020




Abstract

Introduction: The interest reached by the medical community of the intestinal microbiota, its alteration as a cause of dysbiosis and relationship in health and disease is exposed. 

Objectives: Review the most recent criteria related to gut dysbiosis.

Discussion: The role of the intestinal microbiota and its microbiome in health and disease, the value of the omic methods for its knowledge and the participation of the imbalance of the intestinal microbiota in the production of dysbiosis, the predisposing factors, causes, effects, are exposed. intestinal and systemic diseases related to dysbiosis and the action of intestinal modulation in the dysbiosis management.

Conclusion: Attention is drawn to the importance of gut dysbiosis as a decisive factor in the production of digestive and extradigestive diseases in childhood and adult individuals and the value of the manipulation of the intestinal microbiota for its treatment.

Keywords: Gut Dysbiosis; Intestinal Microbiota

References

  1. Gilbert JA., et al. “Current understanding of the human microbiome”. Nature 24 (2018): 392-400. 
  2. Castañeda C. “Intestinal microbiota and child health”. Revista Cubana Pediatrica 90.1 (2018): 94-110.
  3. Rowland I., et al. “Gut microbiota functions: metabolism of nutrients and other food components”. European Journal of Nutrition 57.1 (2018): 1-24. 
  4. Singh RP and Kotari R. “Chapter 1. The omics era and host microbiome. Part 1. Next Generation Sequence Technology”. In: Understanding host-microbiome-interactions. An omics approach. Ed. Singh RP, Kothari R, Koringa PG, Singh SP. Springer. Singapore (2017): 3-12.
  5. Richard ML and Sokol H. “The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases”. Nature Reviews Gastroenterology and Hepatology 16 (2019): 331-345.
  6. Belizário JE and Faintuch J. “Microbiome and Gut Dysbiosis” (2018): 459-476.
  7. Lobionda S., et al. “The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors”. Microorganisms 7.8 (2018): 271. 
  8. Hawrelak JA and Myers SP. “The causes of intestinal dysbiosis: a review”. Alternative Medicine Review 9.2 (2004): 180-197.
  9. Belizário JE., et al. “Gut microbome dysbiosis and immunometabolism: New frontiers for treatment of Metabolic diseases”. Mediators of Inflammation 9 (2018): 2037838.
  10. Fukui H. “Role of Gut Dysbiosis in Liver Diseases: What have we learned so far?”. Diseases 7.4 (2019): 58. 
  11. Pascal M., et al. “Microbiome and Allergic Diseases”. Frontiers in Immunology 9 (2018): 1584. 
  12. Sun L., et al. “Insights into the role of gut microbiota in obesity: Pathogenesis, mechanisms, and therapeutic perspectives”. Protein and Cell 9.5 (2018): 397-403. 
  13. Castaner O., et al. “The Gut Microbiome profile in obesity: A systematic review”. International Journal of Endocrinology 2018 (2018): 4095789. 
  14. McCann J., et al. “The microbiome intestinal and childhood obesity”. Current Pediatrics Report 5.3 (2017): 150-155. 
  15. Beer K. “The gut microbiome in type 2 diabetes”. Clinician Reviews 28.2 (2018): 13-16. 
  16. Sircana A., et al. “Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?”. Current Diabetes Reports 18.10 (2018): 98. 
  17. MacQueen G., et al. “The gut microbiota and psychiatric illness”. Journal of Psychiatry and Neuroscience 42.2 (2017): 75-77. 
  18. Andreo P., et al. “The gut microbiota and its relation to mental illnesses through the microbiota-gut-brain axis”. Clinical Neurology 4.2 (2017): 52-58. 
  19. Srikantha P and Mohajeri MH. “The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder”. International Journal of Molecular Sciences 20.9 (2019): E2115. 
  20. Liu F., et al. “Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review”. Translational Psychiatry 43 (2019). 
  21. Sherwin E., et al. “Recent developments in understanding the role of the gut microbiota in brain health and disease”. Annals of the New York Academy of Sciences 1420.1 (2018): 5-25. 
  22. Chelakkot C., et al. “Mechanisms regulating intestinal barrier Integrity an its pathological implications”. Experimental and Molecular Medicine 50.8 (2018): 103.
  23. Tsai Y-L., et al. “Probiotics, prebiotics and amelioration of diseases”. Journal of Biomedical Science (2019).
  24. Guarner F., et al. World Gastroenterology Organisation. Probiotics and Prebiotics (2017). 
  25. Khalesi S., et al. “A review of probiotic supplementation in healthy adults: helpful or hype?”. European Journal of Clinical Nutrition 73 (2018): 24-37.
  26. Markowiak P and Sliżewska K. “Effects of Probiotics, Prebiotics, and Simbiotics on Human Health”. Nutrients 9.9 (2017): 102. 
  27. Kim S., et al. “Safety and effectiveness of fecal microbiota transplantation: a systematic review”. Journal of the Korean Association 60.9 (2017): 761-768.
  28. Davidovics ZH., et al. “Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and other conditions in children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, Nutrition, the European Society for Pediatric Gastroenterology Hepatology, Nutrition”. Journal of Pediatric Gastroenterology and Nutrition 68.1 (2019): 130-143. 
  29. Chang C-J., et al. “Next generation probiotics in disease amelioration”. Journal of Food and Drug Analysis 27.3 (2019): 615-622. 
  30. Porras D., et al. “Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease”. Frontiers in Physiology 18.9 (2018): 1813.
Citation: Carlos Castañeda Guillot. “Gut Dysbiosis”. EC Gastroenterology and Digestive System 7.3 (2020): 01-04.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.